This article presents a series of hypothetical case studies that represent some of the more common therapeutic dilemmas that primary care clinicians face in their daily management of patients with T2DM. ...
Louis Kuritzky, MD; Eric A. Dietrich, PharmD, BCPS
The advent of a variety of methodologically new antithrombotic agents has provided clinicians with important choices to make when selecting treatments for commonplace syndromes, such as atrial...
Louis Kuritzky, MD; Eric A. Dietrich, PharmD, BCPS
For 65 years, warfarin has been widely used as an effective medication in the prevention of venous thromboembolism for a variety of disease states, including atrial fibrillation, as well as for the...
Louis Kuritzky, MD; Kristin Steffes, MD; David Wymer
This article provides an overview of acne vulgaris, with a focus on inflammatory and post-adolescent acne, and outlines a framework that primary care physicians can use to effectively treat these patients.
...
Louis Kuritzky, MD; Eric A. Dietrich, PharmD, BCPS
LH is a 60-year-old white male with a 10-year history of longstanding hypertension as well as systolic heart failure (sys-HF) with a reduced ejection fraction (EF) of 20%.
Eric A. Dietrich, PharmD, BCPS; Louis Kuritzky, MD
As with the decision to initiate or continue warfarin therapy, decisions surrounding bridge therapy are patient-specific and should be evaluated on a case-by-case basis.
Louis Kuritzky, MD; Eric A. Dietrich, PharmD, BCPS
We have recently been following KD, a 58-year-old male who was diagnosed with a first unprovoked deep vein thrombosis (DVT). After completing 3 months of treatment with warfarin, KD elected to continue...
Louis Kuritzky, MD; Eric A. Dietrich, PharmD, BCPS
Unprovoked DVT is a term used to describe the occurrence of DVT in the absence of currently recognized triggers, such as surgery, long-haul travel, immobilization, or trauma.